Trial Profile
RAndomized trial of Legflow PaclItaxel Eluting Balloon (LPEB) with stentplacement vs. stanDard percutaneous transluminal angioplasty (PTA) with stentplacement for the treatment of intermediate (>5 cm and < 15 cm) and long (>15 cm) lesions of the superficial femoral artery (SFA): The RAPID trial
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Aug 2019
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary)
- Indications Atherosclerosis; Coronary artery restenosis
- Focus Therapeutic Use
- Acronyms RAPID
- 13 Jan 2014 Status changed from recruiting to completed as reported in ISRCTN: Current Controlled Trials record.
- 07 Aug 2012 New trial record